retatrutide approval status 2025 fda Retatrutide, a Superpowerful Obesity Drug, Is Not Yet FDA-Approved — but Knockoffs Abound Quantity:2 Bottles (60 Day Supply) GLP-1Care Results were over 72

retatrutide approval status 2025 fda Retatrutide, a Superpowerful Obesity Drug, Is Not Yet FDA-Approved — but Knockoffs Abound Quantity:2 Bottles (60 Day Supply) GLP-1Care Results were over 72

Results were over 72 weeks. Mounjaro (Tirzapatide) is a GLP-1 + GIP, dual-acting drug. The GLP (Glucagon Like Peptide)-1 component is mainly known for appetite control, but it also: • Improves insulin

It ensures a gradual and controlled increase in serum potassium levels

GLP-1Care

Quantity:2 Bottles (60 Day Supply)

While initial interest is strong, it's important to note that substantive scientific backing is still in development